Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07391579
Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients
Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
Sponsor: Ain Shams University
Conditions
Erectile Dysfunctions
Interventions
Sildenafil 100mg & placebo Tadalafil 5 mg & Sildenafil 100mg
Updated 1 time since 2026 Last updated: Feb 2, 2026 Started: Dec 1, 2025 Primary completion: Dec 31, 2026 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07391579, this PHASE4 trial focuses on Erectile Dysfunctions and remains actively recruiting participants. Sponsored by Ain Shams University, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ain Shams University
- Al-Azhar University
- Alexandria University
- Assiut University
- Aswan University
- Cairo University
- Luxor university
- Mansoura University
- Minia University
- October 6 University
- Tanta University
Data source: Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .